Christopher Schriever
Overview
Explore the profile of Christopher Schriever including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ziegler J, Chapman H, Rueth M, Hays A, Schriever C, Tsaras G
J Pediatr Pharmacol Ther
. 2020 Apr;
25(3):266-269.
PMID: 32265613
Extended-spectrum β-lactamases (ESBL) are produced mainly by members of the Enterobacteriaceae family and confer resistance to most β-lactam antibiotics. Because of limited treatment options, ESBL infections are typically more challenging...
2.
Ahmed A, Schriever C, Britt N, Yager J, Amin R, McGuey L, et al.
Ann Hepatol
. 2019 May;
18(4):601-606.
PMID: 31078440
Introduction And Objectives: Four regimens are recommended for treating hepatitis C (HCV) genotype 1 infection. Study aims were to (1) compare frequencies of contraindicated drug interactions (XDDIs) when each HCV...
3.
Hemenway A, Christensen A, Schriever C
Am J Health Syst Pharm
. 2018 Nov;
75(22):1775-1782.
PMID: 30404894
Purpose: The clinical and microbiological data for urinary tract infections (UTIs) for 6 organisms detected by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) at community health systems were examined. Summary: The...
4.
Hays A, Schriever C, Rudzinski J, Lynch J, Genrich E, Schriever A
Am J Public Health
. 2018 Feb;
108(3):358-360.
PMID: 29412719
We expanded health care services to economically disadvantaged individuals in an interprofessional, student-driven vaccination effort that also served as a pandemic planning drill. Health care professional students from colleges in...
5.
Bunnell K, Aldossari A, Perkins C, Schriever C, Chiampas T, Young J, et al.
J Int Assoc Provid AIDS Care
. 2018 Jan;
17:2325957417752261.
PMID: 29357770
Background: Obesity is common among patients with HIV. The objective of this study was to characterize response to antiretroviral therapy (ART) in a cohort of obese incarcerated adults compared to...
6.
Johnson S, Schriever C, Patel U, Patel T, Hecht D, Gerding D
Anaerobe
. 2009 Aug;
15(6):290-1.
PMID: 19698797
We report our continued experience with rifaximin as a post-vancomycin treatment strategy in six patients with multiple recurrences of C. difficile infection (CDI). Four of the six patients (67%) had...
7.
Johnson S, Schriever C, Galang M, Kelly C, Gerding D
Clin Infect Dis
. 2007 Feb;
44(6):846-8.
PMID: 17304459
Eight women who each experienced 4-8 episodes of Clostridium difficile-associated diarrhea were given a 2-week course of rifaximin therapy when they were asymptomatic, immediately after completing their last course of...
8.
Rubinstein I, Kumar B, Schriever C
Respir Med
. 2004 Feb;
98(2):134-8.
PMID: 14971876
The purpose of this retrospective study was to determine the effects of long-term treatment with montelukast on chronic obstructive pulmonary disease (COPD) control in a cohort of patients with moderate...
9.
Schriever C, Pendland S, Mahady G
Atherosclerosis
. 2003 Dec;
171(2):379-80.
PMID: 14644410
No abstract available.